MC
HUMAW icon

Meteora Capital’s Humacyte Inc Warrant HUMAW Stock Holding History

Meteora Capital’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-97,671
Closed -$136K – 218
2024
Q2 		$136K Buy
+97,671
New +$121K 0.02% 160

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Meteora Capital's HUMAW Position: Q3 2024 in Review

Meteora Capital sold out of Humacyte Inc Warrant (HUMAW) in Q3 2024, closing a stake of 97,671 shares — an estimated $136K sold.

Meteora Capital first reported a position in HUMAW in Q2 2024 and held it in 1 quarter. The position peaked at $136K in Q2 2024. 7 funds tracked by Wall St. Rank hold HUMAW as of Q3 2024.

  • Meteora Capital reported no remaining Humacyte Inc Warrant position as of Q3 2024 after selling out during the quarter.
  • Meteora Capital sold 97,671 Humacyte Inc Warrant shares in Q3 2024, an estimated $136K.
  • Meteora Capital first reported a position in Humacyte Inc Warrant in Q2 2024 and held it in 1 quarter.
  • Meteora Capital's Humacyte Inc Warrant position peaked at $136K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q3 2024.

Based on Meteora Capital's 13F filing for Q3 2024, filed 14 Nov 2024.